Rodent models: Utility for candidate gene studies in human attention-deficit hyperactivity disorder (ADHD)

Journal of Neuroscience Methods

Volumn 166, Issue 2, 2007, Pages 294-305

  Mill, Jonathan ^a,b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Animal model; Attention deficit hyperactivity disorder (ADHD); Behavior; Candidate gene; Genetics; Quantitative trait loci (QTL); Rodents

Indexed keywords

AMPHETAMINE; CLOZAPINE; COCAINE; METHYLPHENIDATE; PSYCHOSTIMULANT AGENT;

ARTICLE; ATTENTION DEFICIT DISORDER; DOPAMINE D4 RECEPTOR GENE; DOPAMINE TRANSPORTER GENE; GENE; GENE IDENTIFICATION; HUMAN; LOW DRUG DOSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS MAPPING; RODENT; SNAP 25 GENE;

ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; DISEASE MODELS, ANIMAL; HUMANS; QUANTITATIVE TRAIT LOCI; RODENTIA;

EID: 35548978128     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2006.11.018     Document Type: Article

References (106)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed., Washington D.C., American Psychiatric Association. 1994.
2. Arcos-Burgos M., Castellanos F.X., Pineda D., Lopera F., Palacio J.D., Palacio L.G., et al. Attention-deficit/hyperactivity disorder in a population isolate: linkage to loci at 4q13.2, 5q33.3, 11q22, and 17p11. Am J Hum Genet 75 6 (2004) 998-1014
3. Asghari V., Sanyal S., Buchwaldt S., Paterson A., Jovanovic V., and Van Tol H.H. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J Neurochem 65 3 (1995) 1157-1165
4. Avale M.E., Falzone T.L., Gelman D.M., Low M.J., Grandy D.K., and Rubinstein M. The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder. Mol Psychiatr 9 7 (2004) 718-726
5. Bakker S.C., van der Meulen E.M., Buitelaar J.K., Sandkuijl L.A., Pauls D.L., Monsuur A.J., et al. A whole-genome scan in 164 Dutch sib pairs with attention-deficit/hyperactivity disorder: suggestive evidence for linkage on chromosomes 7p and 15q. Am J Hum Genet 72 5 (2003) 1251-1260
6. Barkley, and Russell A. ADHD and the nature of self-control (1997), The Guilford Press, New York
7. Barkley R.A., Fischer M., Smallish L., and Fletcher K. The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J Abnorm Psychol 111 2 (2002) 279-289
8. Benjamin J., Li L., Patterson C., Greenberg B.D., Murphy D.L., Hamer D.H., et al. Familial association between the D4 dopamine receptor gene and measures of novelty seeking. Nat Genet 12 1 (1996) 81-84
9. Biederman J., Faraone S.V., Milberger S., and Doyle A. Diagnoses of attention-deficit hyperactivity disorder from parent reports predict diagnoses based on teacher reports. J Am Acad Child Adolesc Psychiatr 32 2 (1993) 315-317
10. Bosse R., Fumagalli F., Jaber M., Giros B., Gainetdinov R.R., Wetsel W.C., et al. Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter. Neuron 19 1 (1997) 127-138
11. Boyle M.H., Offord D.R., Racine Y.A., Szatmari P., Sanford M., and Fleming J.E. Adequacy of interviews vs checklists for classifying childhood psychiatric disorder based on parent reports. Arch Gen Psychiatr 54 9 (1997) 793-799
12. Brookes K.J., Mill J., Guindalini C., Curran S., Xu X., Knight J., et al. A common haplotype of the dopamine transporter gene associated with attention-deficit/hyperactivity disorder and interacting with maternal use of alcohol during pregnancy. Arch Gen Psychiatr 63 1 (2006) 74-81
13. Bruno K.J., and Hess E.J. The alpha(2C)-adrenergic receptor mediates hyperactivity of coloboma mice, a model of attention deficit hyperactivity disorder. Neurobiol Dis 23 3 (2006) 679-688
14. Cabib S., Puglisi-Allegra S., and Ventura R. The contribution of comparative studies in inbred strains of mice to the understanding of the hyperactive phenotype. Behav Brain Res 130 1/2 (2002) 103-109
15. Carboni E., Spielewoy C., Vacca C., Nosten-Bertrand M., Giros B., and Di Chiara G. Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene. J Neurosci 21 9 (5-1-2001) RC141-RC144
16. Castellanos F.X., Sharp W.S., Gottesman R.F., Greenstein D.K., Giedd J.N., and Rapoport J.L. Anatomic brain abnormalities in monozygotic twins discordant for attention deficit hyperactivity disorder. Am J Psychiatr 160 9 (2003) 1693-1696
17. Chesler E.J., Lu L., Wang J., Williams R.W., and Manly K.F. WebQTL: rapid exploratory analysis of gene expression and genetic networks for brain and behavior. Nat Neurosci 7 5 (2004) 485-486
18. Cook Jr. E.H., Stein M.A., Krasowski M.D., Cox N.J., Olkon D.M., Kieffer J.E., et al. Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 56 4 (1995) 993-998
19. Cornish K.M., Manly T., Savage R., Swanson J., Morisano D., Butler N., et al. Association of the dopamine transporter (DAT1) 10/10-repeat genotype with ADHD symptoms and response inhibition in a general population sample. Mol Psychiatr 10 7 (2005) 686-698
20. Curran S., Mill J., Tahir E., Kent L., Richards S., Gould A., et al. Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples. Mol Psychiatr 6 4 (2001) 425-428
21. Davids E., Zhang K., Tarazi F.I., and Baldessarini R.J. Animal models of attention-deficit hyperactivity disorder. Brain Res Brain Res Rev 42 1 (2003) 1-21
22. De Luca V., Muglia P., Vincent J.B., Lanktree M., Jain U., and Kennedy J.L. Adrenergic alpha 2C receptor genomic organization: association study in adult ADHD. Am J Med Genet B Neuropsychiatr Genet 127 1 (2004) 65-67
23. DeFries J.C., and Fulker D.W. Multiple regression analysis of twin data: aetiology of deviant scores versus individual differences. Acta Genet Med Gemellol (Roma) 37 3/4 (1988) 205-216
24. Dougherty D.D., Bonab A.A., Spencer T.J., Rauch S.L., Madras B.K., and Fischman A.J. Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet 354 9196 (12-18-1999) 2132-2133
25. Dresel S., Krause J., Krause K.H., LaFougere C., Brinkbaumer K., Kung H.F., et al. Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment. Eur J Nucl Med 27 10 (2000) 1518-1524
26. Dulawa S.C., Grandy D.K., Low M.J., Paulus M.P., and Geyer M.A. Dopamine D4 receptor-knock-out mice exhibit reduced exploration of novel stimuli. J Neurosci 19 21 (1999) 9550-9556
27. Eaves L.J., Silberg J.L., Meyer J.M., Maes H.H., Simonoff E., Pickles A., et al. Genetics and developmental psychopathology: 2. The main effects of genes and environment on behavioral problems in the virginia twin study of adolescent behavioral development. J Child Psychol Psychiatr 38 8 (1997) 965-980
28. Ebstein R.P., Novick O., Umansky R., Priel B., Osher Y., Blaine D., et al. Dopamine D4 receptor (D4DR) Exon III polymorphism associated with the human personality trait of novelty seeking. Nat Genet 12 1 (1996) 78-80
29. Faraone S.V., Spencer T., Aleardi M., Pagano C., and Biederman J. Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol 24 1 (2004) 24-29
30. Faraone S.V., Perlis R.H., Doyle A.E., Smoller J.W., Goralnick J.J., Holmgren M.A., et al. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatr 57 11 (2005) 1313-1323
31. Feng Y., Crosbie J., Wigg K., Pathare T., Ickowicz A., Schachar R., et al. The SNAP25 gene as a susceptibility gene contributing to attention-deficit hyperactivity disorder. Mol Psychiatr 10 11 (2005) 998-1005 973
32. Feng Y., Wigg K.G., Makkar R., Ickowicz A., Pathare T., Tannock R., et al. Sequence variation in the 3'-untranslated region of the dopamine transporter gene and attention-deficit hyperactivity disorder (ADHD). Am J Med Genet B Neuropsychiatr Genet 139 1 (2005) 1-6
33. Flint J., Valdar W., Shifman S., and Mott R. Strategies for mapping and cloning quantitative trait genes in rodents. Nat Rev Genet 6 4 (2005) 271-286
34. Gainetdinov R.R., Wetsel W.C., Jones S.R., Levin E.D., Jaber M., and Caron M.G. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283 5400 (1999) 397-401
35. Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J., Scherer S., et al. Genome sequence of the brown Norway rat yields insights into mammalian evolution. Nature 428 6982 (2004) 493-521
36. Giros B., Jaber M., Jones S.R., Wightman R.M., and Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379 6566 (1996) 606-612
37. Godinho S.I., and Nolan P.M. The role of mutagenesis in defining genes in behaviour. Eur J Hum Genet 14 6 (2006) 651-659
38. Granon S., Faure P., Changeux J.P., and Executive. Social behaviors under nicotinic receptor regulation. Proc Natl Acad Sci USA 100 16 (2003) 9596-9601
39. Granon S., and Changeux J.P. Attention-deficit/hyperactivity disorder: a plausible mouse model?. Acta Paediatr 95 6 (2006) 645-649
40. Hebebrand J., Dempfle A., Saar K., Thiele H., Herpertz-Dahlmann B., Linder M., et al. A genome-wide scan for attention-deficit/hyperactivity disorder in 155 German sib-pairs. Mol Psychiatr 11 2 (2006) 196-205
41. Heinz A., Goldman D., Jones D.W., Palmour R., Hommer D., Gorey J.G., et al. Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 22 2 (2000) 133-139
42. Hendley E.D., Wessel D.J., and Van Houten J. Inbreeding of Wistar-Kyoto rat strain with hyperactivity but without hypertension. Behav Neural Biol 45 1 (1986) 1-16
43. Hess E.J., Jinnah H.A., Kozak C.A., and Wilson M.C. Spontaneous locomotor hyperactivity in a mouse mutant with a deletion including the snap gene on Chromosome 2. J Neurosci 12 7 (1992) 2865-2874
44. Hess E.J., Collins K.A., and Wilson M.C. Mouse model of hyperkinesis implicates SNAP-25 in behavioral regulation. J Neurosci 16 9 (1996) 3104-3111
45. Hitotsumachi S., Carpenter D.A., and Russell W.L. Dose-repetition increases the mutagenic effectiveness of N-ethyl-N-nitrosourea in mouse spermatogonia. Proc Natl Acad Sci USA 82 19 (1985) 6619-6621
46. Jacobsen L.K., Staley J.K., Zoghbi S.S., Seibyl J.P., Kosten T.R., Innis R.B., et al. Prediction of dopamine transporter binding availability by genotype: a preliminary report. Am J Psychiatr 157 10 (2000) 1700-1703
47. Janowsky A., Mah C., Johnson R.A., Cunningham C.L., Phillips T.J., Crabbe J.C., et al. Mapping genes that regulate density of dopamine transporters and correlated behaviors in recombinant inbred mice. J Pharmacol Exp Ther 298 2 (2001) 634-643
48. Jensen P.S., Martin D., and Cantwell D.P. Comorbidity in ADHD: implications for research, practice, and DSM-V. J Am Acad Child Adolesc Psychiatr 36 8 (1997) 1065-1079
49. Jiao X., Pare W.P., and Tejani-Butt S. Strain differences in the distribution of dopamine transporter sites in rat brain. Prog Neuropsychopharmacol Biol Psychiatry 27 6 (2003) 913-919
50. Jones M.D., and Hess E.J. Norepinephrine regulates locomotor hyperactivity in the mouse mutant coloboma. Pharmacol Biochem Behav 75 1 (2003) 209-216
51. Kazmi M.A., Snyder L.A., Cypess A.M., Graber S.G., and Sakmar T.P. Selective reconstitution of human D4 dopamine receptor variants with Gi alpha subtypes. Biochemistry 39 13 (4-4-2000) 3734-3744
52. Kent L., Middle F., Hawi Z., Fitzgerald M., Gill M., Feehan C., et al. Nicotinic acetylcholine receptor Alpha4 subunit gene polymorphism and attention deficit hyperactivity disorder. Psychiatr Genet 11 1 (2001) 37-40
53. Kirley A., Lowe N., Hawi Z., Mullins C., Daly G., Waldman I., et al. Association of the 480 Bp DAT1 allele with methylphenidate response in a sample of Irish children with ADHD. Am J Med Genet B Neuropsychiatr Genet 121 1 (2003) 50-54
54. Konrad K., Gunther T., Hanisch C., and Herpertz-Dahlmann B. Differential effects of methylphenidate on attentional functions in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatr 43 2 (2004) 191-198
55. Levy F., Hay D.A., McStephen M., Wood C., and Waldman I. Attention-deficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large-scale twin study. J Am Acad Child Adolesc Psychiatry 36 6 (1997) 737-744
56. Madras B.K., Miller G.M., and Fischman A.J. The dopamine transporter and attention-deficit/hyperactivity disorder. Biol Psychiatr 57 11 (6-1-2005) 1397-1409
57. McClearn G.E., Wilson J.R., and Meredith W. The use of isogenic and heterogenic mouse stocks in behavioral research, in Contribution to behavior genetic analysis. In: Lindzey G., and Thiessen D.D. (Eds). The mouse as a prototype (1970), Appleton-Century-Crofts, New York 3-32
58. McDonald M.P., Wong R., Goldstein G., Weintraub B., Cheng S.Y., and Crawley J.N. Hyperactivity and learning deficits in transgenic mice bearing a human mutant thyroid hormone beta1 receptor gene. Learn Mem 5 4/5 (1998) 289-301
59. McGough J.J. Attention-deficit/hyperactivity disorder pharmacogenomics. Biol Psychiatr 57 11 (2005) 1367-1373
60. Meyer J.H., Kruger S., Wilson A.A., Christensen B.K., Goulding V.S., Schaffer A., et al. Lower dopamine transporter binding potential in striatum during depression. Neuroreport 12 18 (2001) 4121-4125
61. Mill J., Asherson P., Browes C., D'Souza U., and Craig I. Expression of the dopamine transporter gene is regulated by the 3′ UTR VNTR: evidence from brain and lymphocytes using quantitative RT-PCR. Am J Med Genet 114 8 (2002) 975-979
62. Mill J., Galsworthy M.J., Paya-Cano J.L., Sluyter F., Schalkwyk L.C., Plomin R., et al. Home-cage activity in heterogeneous stock (HS) mice as a model of baseline activity. Genes Brain Behav 1 3 (2002) 166-173
63. Mill J., Richards S., Knight J., Curran S., Taylor E., and Asherson P. Haplotype analysis of SNAP-25 suggests a role in the aetiology of ADHD. Mol Psychiatr 9 8 (2004) 801-810
64. Mill J., Xu X., Ronald A., Curran S., Price T., Knight J., et al. Quantitative trait locus analysis of candidate gene alleles associated with attention deficit hyperactivity disorder (ADHD) in five genes: DRD4, DAT1, DRD5, SNAP-25, and 5HT1B. Am J Med Genet B Neuropsychiatr Genet 133 1 (2-5-2005) 68-73
65. Mill J., Sagvolden T., and Asherson P. Sequence analysis of Drd2, Drd4, and Dat1 in SHR and WKY rat strains. Behav Brain Funct 1 (2005) 24
66. Mill J., Caspi A., Williams B.S., Craig I., Taylor A., Polo-Tomas M., et al. Prediction of heterogeneity in intelligence and adult prognosis by genetic polymorphisms in the dopamine system among children with attention-deficit/hyperactivity disorder: evidence from 2 birth cohorts. Arch Gen Psychiatr 63 4 (2006) 462-469
67. Moisan M.P., Courvoisier H., Bihoreau M.T., Gauguier D., Hendley E.D., Lathrop M., et al. A major quantitative trait locus influences hyperactivity in the WKHA rat. Nat Genet 14 4 (1996) 471-473
68. Mormede P., Moneva E., Bruneval C., Chaouloff F., and Moisan M.P. Marker-assisted selection of a neuro-behavioural trait related to behavioural inhibition in the SHR strain, an animal model of ADHD. Genes Brain Behav 1 2 (2002) 111-116
69. Nadeau J.H., and Frankel W.N. The roads from phenotypic variation to gene discovery: mutagenesis versus QTLs. Nat Genet 25 4 (2000) 381-384
70. Nigg J.T., Willcutt E.G., Doyle A.E., and Sonuga-Barke E.J. Causal heterogeneity in attention-deficit/hyperactivity disorder: do we need neuropsychologically impaired subtypes?. Biol Psychiatr 57 11 (2005) 1224-1230
71. Nolan P.M., Peters J., Strivens M., Rogers D., Hagan J., Spurr N., et al. A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse. Nat Genet 25 4 (2000) 440-443
72. Oades R.D. Dopamine may be 'hyper' with respect to noradrenaline metabolism, but 'hypo' with respect to serotonin metabolism in children with attention-deficit hyperactivity disorder. Behav Brain Res 130 1/2 (2002) 97-102
73. Ogdie M.N., Fisher S.E., Yang M., Ishii J., Francks C., Loo S.K., et al. Attention deficit hyperactivity disorder: fine mapping supports linkage to 5p13, 6q12, 16p13, and 17p11. Am J Hum Genet 75 4 (2004) 661-668
74. Okamoto K., and Aoki K. Development of a strain of spontaneously hypertensive rats. Jpn Circ J 27 (1963) 282-293
75. Osen-Sand A., Catsicas M., Staple J.K., Jones K.A., Ayala G., Knowles J., et al. Inhibition of axonal growth by SNAP-25 antisense oligonucleotides in vitro and in vivo. Nature 364 6436 (1993) 445-448
76. Oyler G.A., Higgins G.A., Hart R.A., Battenberg E., Billingsley M., Bloom F.E., et al. The identification of a novel synaptosomal-associated protein, SNAP-25, Differentially Expressed By Neuronal Subpopulations. J Cell Biol 109 6 Pt 1 (1989) 3039-3052
77. Patel S., Stolerman I.P., Asherson P., and Sluyter F. Attentional performance of C57BL/6 and DBA/2 mice in the 5-choice serial reaction time task. Behav Brain Res 170 2 (2006) 197-203
78. Ramos A., Mellerin Y., Mormede P., Chaouloff F., and Genetic A. Multifactorial analysis of anxiety-related behaviours in lewis and SHR intercrosses. Behav Brain Res 96 1/2 (1998) 195-205
79. Roman T., Szobot C., Martins S., Biederman J., Rohde L.A., and Hutz M.H. Dopamine transporter gene and response to methylphenidate in attention-deficit/hyperactivity disorder. Pharmacogenetics 12 6 (2002) 497-499
80. Rubinstein M., Phillips T.J., Bunzow J.R., Falzone T.L., Dziewczapolski G., Zhang G., et al. Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine. Cell 90 6 (1997) 991-1001
81. Russell V., de Villiers A., Sagvolden T., Lamm M., and Taljaard J. Differences between electrically-, ritalin- and d-amphetamine-stimulated release of [3H]dopamine from brain slices suggest impaired vesicular storage of dopamine in an animal model of attention-deficit hyperactivity disorder. Behav Brain Res 94 1 (1998) 163-171
82. Russell V.A. Dopamine hypofunction possibly results from a defect in glutamate-stimulated release of dopamine in the nucleus accumbens shell of a rat model for attention deficit hyperactivity disorder-the spontaneously hypertensive rat. Neurosci Biobehav Rev 27 7 (2003) 671-682
83. Russell V.A., Sagvolden T., and Johansen E.B. Animal models of attention-deficit hyperactivity disorder. Behav Brain Funct 1 (2005) 9
84. Sagvolden T., Metzger M.A., Schiorbeck H.K., Rugland A.L., Spinnangr I., and Sagvolden G. The spontaneously hypertensive rat (SHR) as an animal model of childhood hyperactivity (ADHD): changed reactivity to reinforcers and to psychomotor stimulants. Behav Neural Biol 58 2 (1992) 103-112
85. Sagvolden T. Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD). Neurosci Biobehav Rev 24 1 (2000) 31-39
86. Sagvolden T., Russell V.A., Aase H., Johansen E.B., and Farshbaf M. Rodent models of attention-deficit/hyperactivity disorder. Biol Psychiatr 57 11 (2005) 1239-1247
87. Shaywitz B.A., Yager R.D., and Klopper J.H. Selective brain dopamine depletion in developing rats: an experimental model of minimal brain dysfunction. Science 191 4224 (1976) 305-308
88. Siesser W.B., Zhao J., Miller L.R., Cheng S.Y., and McDonald M.P. Transgenic mice expressing a human mutant beta1 thyroid receptor are hyperactive, impulsive, and inattentive. Genes Brain Behav 5 3 (2006) 282-297
89. Silver L.M. Mouse genetics (1995), Oxford University Press, New York
90. Spencer T.J., Biederman J., Wilens T.E., and Faraone S.V. Overview and neurobiology of attention-deficit/hyperactivity disorder. J Clin Psychiatr 63 Suppl 12 (2002) 3-9
91. Sprich S., Biederman J., Crawford M.H., Mundy E., and Faraone S.V. Adoptive and biological families of children and adolescents with ADHD. J Am Acad Child Adolesc Psychiatr 39 11 (2000) 1432-1437
92. Stein M.A., Weiss R.E., and Refetoff S. Neurocognitive characteristics of individuals with resistance to thyroid hormone: comparisons with individuals with attention-deficit hyperactivity disorder. J Dev Behav Pediatr 16 6 (1995) 406-411
93. Thapar A. Attention deficit hyperactivity disorder: new genetic findings, new directions. In: Plomin R., DeFries J., Craig I., and McGuffin P. (Eds). Behavioural genetics in the postgenomic era (2002), APA, Washington 445-462
94. Ueno K., Togashi H., Matsumoto M., Ohashi S., Saito H., and Yoshioka M. Alpha4beta2 nicotinic acetylcholine receptor activation ameliorates impairment of spontaneous alternation behavior in stroke-prone spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder. J Pharmacol Exp Ther 302 1 (2002) 95-100
95. van Dyck C.H., Quinlan D.M., Cretella L.M., Staley J.K., Malison R.T., Baldwin R.M., et al. Unaltered dopamine transporter availability in adult attention deficit hyperactivity disorder. Am J Psychiatr 159 2 (2002) 309-312
96. Van Tol H.H., Bunzow J.R., Guan H.C., Sunahara R.K., Seeman P., Niznik H.B., et al. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 350 6319 (1991) 610-614
97. Van Tol H.H., Wu C.M., Guan H.C., Ohara K., Bunzow J.R., Civelli O., et al. Multiple dopamine D4 receptor variants in the human population. Nature 358 6382 (1992) 149-152
98. VanNess S.H., Owens M.J., and Kilts C.D. The variable number of tandem repeats element in DAT1 regulates in vitro dopamine transporter density. BMC Genet 6 (2005) 55
99. Vendruscolo L.F., Terenina-Rigaldie E., Raba F., Ramos A., Takahashi R.N., and Mormede P. A QTL on rat chromosome 7 modulates prepulse inhibition, a neuro-behavioral trait of ADHD, in a Lewis × SHR intercross. Behav Brain Funct 2 (2006) 21
100. Viggiano D., Grammatikopoulos G., and Sadile A.G. A morphometric evidence for a hyperfunctioning mesolimbic system in an animal model of ADHD. Behav Brain Res 130 1/2 (2002) 181-189
101. Watanabe Y., Fujita M., Ito Y., Okada T., Kusuoka H., and Nishimura T. Brain dopamine transporter in spontaneously hypertensive rats. J Nucl Med 38 3 (1997) 470-474
102. Waterston R.H., Lindblad-Toh K., Birney E., Rogers J., Abril J.F., Agarwal P., et al. Initial sequencing and comparative analysis of the mouse genome. Nature 420 6915 (2002) 520-562
103. Watts V.J., Vu M.N., Wiens B.L., Jovanovic V., Van Tol H.H., Neve K.A., et al. Long-term heterologous sensitization of adenylate cyclase by D4 dopamine receptors. Psychopharmacology (Berl) 141 1 (1999) 83-92
104. Winsberg B.G., and Comings D.E. Association of the dopamine transporter gene (DAT1) with poor methylphenidate response. J Am Acad Child Adolesc Psychiatr 38 12 (1999) 1474-1477
105. Zhang X., Beaulieu J.M., Sotnikova T.D., Gainetdinov R.R., and Caron M.G. Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science 305 5681 (2004) 217
106. Zhuang X., Oosting R.S., Jones S.R., Gainetdinov R.R., Miller G.W., Caron M.G., et al. Hyperactivity and impaired response habituation in hyperdopaminergic mice. Proc Natl Acad Sci USA 98 4 (2001) 1982-1987